Cencora stock trades at EUR 291.90 with USD 63.3 billion value

Published on 10/12/2026 at 16:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cencora stock is EUR 291.90 on October 12, 2026 between EUR 291.40 bid and EUR 292.40 ask. Market value is USD 63.3 billion and P/E is 24.2.

Key points in brief

Cencora stock was trading at EUR 291.90 at Lang & Schwarz on October 12, 2026.
The quote stood between a EUR 291.40 bid and EUR 292.40 ask, with a USD 63.3 billion market capitalization.
Cencora had a 24.2 P/E ratio and a USD 244.82 to USD 377.54 52-week range.
Cencora is scheduled to report fourth-quarter fiscal 2026 results on November 4, 2026.

Luftbild eines modernen Pharma-Lagerzentrums mit Lieferfahrzeugen und Verladedocks — Cencora Inc. betreibt US15135B1017 ein großes Pharmadistributionszentrum mit Lastwagen Gabelstaplern und täglicher Medikamentenlogistik, Illustration mit AI erstellt.

Cencora Inc. (ISIN US03073E1055) was trading at EUR 291.90 at Lang & Schwarz on October 12, 2026 at 4:42 p.m. CEST, between a bid of EUR 291.40 and an ask of EUR 292.40. Its market capitalization was USD 63.3 billion, while the primary-market quote stood at USD 325.60 on the NYSE at 10:52 a.m. ET.

Price sits inside its yearly range

The stock's USD 244.82 to USD 377.54 52-week range places the NYSE quote in the middle portion of its yearly span. The EUR 291.90 German-market quote and the USD primary-market quote are separate currency observations and are not combined into one return figure.

Cencora's valuation measured 24.2 times earnings on October 12, 2026. Trading volume was 148,244 shares against an average volume of 1,322,171, giving the session a comparatively light turnover profile at the time of the quote.

Analyst target remains the main benchmark

MarketBeat reported on October 7, 2026 that Leerink Partners raised its Cencora target from USD 380.00 to USD 388.00 while maintaining an Outperform rating. The same report cited a consensus target of USD 372.07, giving the stock a clear analyst reference point in US dollars.

The target update came ahead of Cencora's next scheduled earnings date. According to Business Wire on October 2, 2026, the company plans to release fourth-quarter fiscal 2026 results before the NYSE opens on November 4, 2026.

Comparison with peers

Cencora Inc.: P/E 24.2, market capitalization USD 63.3 billion
Cardinal Health (NYSE, USD): minus 0.3 percent, P/E 32.7, market capitalization USD 55.5 billion
McKesson Corporation (NYSE, USD): plus 1.3 percent, P/E 25.4, market capitalization USD 111.4 billion

Calendar sets the next checkpoint

The November 4, 2026 earnings release is the next dated company event for the stock. Until then, the market picture is defined by the EUR 291.90 Lang & Schwarz quote, its USD 63.3 billion market value, the 24.2 P/E ratio and the analyst target range cited above.

The further course of trading is shown by the continuously updated real-time quote of Cencora stock.